newsfilter
← Latest News
GlobeNewswire·

Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

BRISBANE, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) ("Tempest"), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies